ERYP News and Press, Erytech Pharma S.A. From 02/09/22

US Ecology ECOL +23% Republic Services is said in talks to purchase US Ecology. Enphase Energy ENPH +22% on Q4 results. ERYTECH Pharma (NASDAQ:ERYP) +13% expands patent portfolio for the treatment of rare metabolic diseases. Biofrontera (NASDAQ:BFRA) +12%. AVROBIO (NASDAQ:...

Erytech Pharma (NASDAQ:ERYP) announces the granting of U.S. patent 11,141,468, covering methods of treating solid tumors by administering methioninase and asparaginase. Shares surge 31.9% premarket at $3.14. The patent, entitled “Method of treating a mammal, including human, ...

Cumberland Pharmaceuticals CPIX +90% on FDA label expansion for pain therapy Pioneer Power Solutions (NASDAQ:PPSI) +66%. First Wave BioPharma (NASDAQ:FWBI) +53% announces independent data monitoring committee provides positive interim safety assessment for part 2 COVID-19 RESER...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re starting off Tuesday with a breakdown of the biggest pre-market stock movers! Source: f11photo/Shutterstock.com News from the FDA, earnings reports, Omicron concerns, and more ar...

ERYTECH Pharma S.A. (ERYP) Q3 2021 Results Conference Call November 16, 2021 08:30 AM ET Company Participants Gil Beyen - Chief Executive Officer Dr. Iman El-Hariry - Chief Medical Officer Eric Soyer - Chief Financial and Chief Operating Officer Conference Call Participants Boris Peaker - Cow...

Today we post our first view on ERYTECH Pharma, a small developmental company located in France. The stock has recently had a sharp pullback following disappointing trial results.  The company still has some potential catalysts on the horizon. Buy the dip or avoid the shares?...

Fossil Group (NASDAQ:FOSL) +32% on Q3 earnings. Babylon (NYSE:BBLN) +28%. Affirm Holdings (NASDAQ:AFRM) +27% on FQ1 earnings. Opendoor Technologies (NASDAQ:OPEN) +18% on Q3 earnings. Society Pass (NASDAQ:SOPA) +19%. ReWalk Robotics (NASDAQ:RWLK) +16% on Q3 earnings. Lordstown Motors...

Tesla. Tesla. Tesla. Elon Musk's electric vehicle giant powered to a $1T market cap on Monday, drawing much of Wall Street's attention during the session. While TSLA dominated most of the spotlight, many smaller players in the EV space also experienced notable gains. XPeng (NYSE:XPEV), Lucid ...

ERYTECH Pharma (NASDAQ: ERYP) reported top results from Phase 3 TRYbeCA-1 clinical trial that evaluates eryaspase as second line treatment in 512 patints with metastatic pancreatic cancer.  The trial did not meet its primary endpoint of overall survival.  “Whi...

Gainers: IceCure Medical (NASDAQ:ICCM) +15%, Kiromic BioPharma KRBP +12%, Eargo (NASDAQ:EAR) +12%, Context Therapeutics (NASDAQ:CNTX) +11%, Xeris Biopharma XERS +11%. Losers: ERYTECH Pharma ERYP -39%, Eyenovia EYEN -37%, Es...